Fiorista F, Brambilla G, Gadaleta G
G Ital Cardiol. 1978;8(1):55-60.
The authors reports data of pacemaker patients surviving above 10 years. They have considered 241 patients undergone pace-maker first insertion from January 1961 to June 1967 (168 treated with epicardial and 73 with transvenous electrodes). At the last control on July 1977, 52 (27 males and 25 females) were surviving, equivalent to 21% of all patients treated in that period. The age of these patients ranged from 5 to 83 (mean 60 years) at first implantation. At present 51 patients are treated with transvenous systems, only 1 patient is stimulated with epicardial pace-maker. 382 pace-makers were used in these 52 patients: the average life of every pacer was 20 months. Complications relative to epicardial and endocardial pacing are reported: with the transvenous system the percent of complications was lower (15,6% to 50,4%). Finally present clinical states of the 52 patients are reported, basing on the reccomendations of Criteria Committee of the New Heart Association.
作者报告了起搏器植入后存活超过10年的患者数据。他们研究了1961年1月至1967年6月期间首次植入起搏器的241例患者（168例采用心外膜电极，73例采用经静脉电极）。在1977年7月的最后一次随访中，有52例（27例男性和25例女性）存活，占该时期所有接受治疗患者的21%。这些患者首次植入时的年龄在5岁至83岁之间（平均60岁）。目前，51例患者采用经静脉系统治疗，只有1例患者使用心外膜起搏器。这52例患者共使用了382个起搏器：每个起搏器的平均使用寿命为20个月。报告了与心外膜起搏和心内膜起搏相关的并发症：经静脉系统的并发症发生率较低（15.6%至50.4%）。最后，根据新心脏协会标准委员会的建议，报告了这52例患者目前的临床状况。
